Skybiotech Healthcare Limited (KAPILCO) is currently trading at 120.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Kapil Cotex Limited, established in 1983, specializes in spinning, weaving, and finishing textiles but shifted away from its primary operations recently. The company has diversified into providing consultancy and assistance for selling goods of foreign clients, significantly earning through brokerage and consultancy income. In addition to its consultancy services, Kapil Cotex Limited engages in trading shares and securities, which serves as another income stream. Despite a lack of revenue from its core textile business, the firm's income from capital gains and dividends remains substantial, highlighting effective financial diversification. Kapil Cotex Limited's strategic pivot towards financial services and foreign client consultancy raises potential questions on its future direction in the textile sector.

Over the past 52 weeks, Skybiotech Healthcare Limited has traded between a low of ₹116.45 and a high of ₹220.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Skybiotech Healthcare Limited has a market capitalization of approximately 23.13. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Skybiotech Healthcare Limited’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of -13.93 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 23.13 Cr, Skybiotech Healthcare Limited is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Skybiotech Healthcare Limited operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Skybiotech Healthcare Limited is -13.93. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.